Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)

CAPS Rating: 2 out of 5

The Company is engaged in the discovery and development of synthetic DNA and RNA-based compounds for the treatment of cancer, infectious diseases, autoimmune diseases, and asthma/allergies, and for use as vaccine adjuvants.

Caps

How do you think IDRA will perform against the market?

Add Stock to CAPS Watchlist

All Players

137 Outperform
22 Underperform
 

All-Star Players

13 Outperform
6 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top IDRA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.85)
Submitted June 17, 2016

Idera's been a confusing stock for me for many years. I started out long in 2010 when the stock seemed to have gotten cheap, only to walk into a buzzsaw of pipeline failures that drove the share price into the pennies. Once I'd given up on the… More

DigitalDisco (94.12)
Submitted July 30, 2018

reverse split

IDRA VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about IDRA.

Recs

1
Member Avatar DigitalDisco (94.12) Submitted: 7/30/2018 1:29:59 PM : Underperform Start Price: $6.58 IDRA Score: -5.58

reverse split

Recs

2
Member Avatar zzlangerhans (99.85) Submitted: 6/17/2016 9:51:49 AM : Outperform Start Price: $1.50 IDRA Score: +313.33

Idera's been a confusing stock for me for many years. I started out long in 2010 when the stock seemed to have gotten cheap, only to walk into a buzzsaw of pipeline failures that drove the share price into the pennies. Once I'd given up on the company, Baker Bros showed up in 2013 and the stock rose 1000% in a year. Things have been pretty choppy for Idera since then and the pipeline bears little resemblance to what is was in 2013. IMO-8400 keeps migrating from indication to indication and management is piggybacking onto the immunooncology trend with IMO-2125. The bottom line is that after a lot of dilution and money spent, Idera is still laboring in early stage trials and hasn't proven anything. Baker Bros has held steady at 7M shares since buying into a large secondary last year. It's hard for me to get excited about Idera but it's also hard to see this stock slipping back into the pennies with the Bakers on board until their lead compounds have clearly failed a la Xoma.

Recs

0
Member Avatar sk2129 (33.86) Submitted: 11/30/2015 4:39:12 PM : Outperform Start Price: $2.73 IDRA Score: +107.02

baker bros.

Leaderboard

Find the members with the highest scoring picks in IDRA.

Score Leader

hayrettin

hayrettin (70.40) Score: +604.09

The Score Leader is the player with the highest score across all their picks in IDRA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
hayrettin 70.40 7/24/2018 Outperform 5Y $0.89 +641.57% -5.92% +647.49 0 Comment
s7evenofspades 44.87 5/3/2012 Outperform 5Y $1.20 +450.00% +89.09% +360.91 0 Comment
zzlangerhans 99.85 6/13/2016 Outperform 1Y $1.50 +339.97% +26.64% +313.33 1 Comment
portefeuille 98.42 5/20/2016 Outperform 5Y $1.50 +340.00% +29.07% +310.93 0 Comment
Momentum21 95.47 10/31/2016 Outperform 5Y $1.60 +312.50% +24.85% +287.65 0 Comment
cottatae < 20 8/6/2013 Outperform 1Y $1.49 +342.98% +56.23% +286.75 0 Comment
amirite 35.69 11/6/2017 Outperform 5Y $1.75 +277.14% +2.74% +274.41 0 Comment
stainsolution 22.89 10/31/2016 Outperform 5Y $1.69 +290.53% +24.63% +265.90 0 Comment
TruffelPig < 20 2/28/2017 Outperform 5Y $1.82 +263.56% +12.03% +251.52 0 Comment
tarikny500 23.41 8/1/2017 Outperform 5Y $1.85 +256.76% +7.24% +249.52 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackRodmanRen < 20 3/24/2010 Outperform NS $5.50 +20.00% +126.87% -106.87 0 Comment
TrackNobleFinanc 30.16 11/21/2008 Outperform NS $5.98 +10.37% +257.19% -246.82 0 Comment
TrackSusquehanna 88.38 5/2/2008 Underperform NS $14.20 -28.73% -38.31% -9.58 10/27/2008 @ $10.12 0 Comment
TrackMDB < 20 5/22/2007 Outperform NS $8.74 -77.00% -9.63% -67.38 4/17/2012 @ $2.01 0 Comment
TrackJanney 84.75 4/18/2007 Outperform NS $8.98 +64.03% -4.22% +68.25 5/7/2008 @ $14.73 0 Comment
trackmerriman 69.38 2/7/2007 Outperform NS $9.45 -30.16% +94.09% -124.25 0 Comment

Advertisement